Falco Holdings Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Falco Holdings Co Ltd with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 13.30 billion Indian Rupees [US$175.35 million]
Medical & Biological Laboratories Company Limited
(9.23 billion Japanese Yen [US$85.65 million]
Thyrocare Technologies Ltd
based in INDIA
(4.33 billion Indian Rupees [US$57.10 million]
Falco Holdings Co Ltd reported sales of ¥43.19 billion (US$400.76 million)
March of 2020.
decrease of 2.2%
versus 2019, when the company's sales were ¥44.16 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Falco Holdings Co Ltd had sales
of ¥46.59 billion.